184 related articles for article (PubMed ID: 23519366)
1. Homogeneous antibody fragment conjugation by disulfide bridging introduces 'spinostics'.
Schumacher FF; Sanchania VA; Tolner B; Wright ZV; Ryan CP; Smith ME; Ward JM; Caddick S; Kay CW; Aeppli G; Chester KA; Baker JR
Sci Rep; 2013; 3():1525. PubMed ID: 23519366
[TBL] [Abstract][Full Text] [Related]
2. Next generation maleimides enable the controlled assembly of antibody-drug conjugates via native disulfide bond bridging.
Schumacher FF; Nunes JP; Maruani A; Chudasama V; Smith ME; Chester KA; Baker JR; Caddick S
Org Biomol Chem; 2014 Oct; 12(37):7261-9. PubMed ID: 25103319
[TBL] [Abstract][Full Text] [Related]
3. Application of Next-Generation Maleimides (NGMs) to Site-Selective Antibody Conjugation.
Morais M; Forte N; Chudasama V; Baker JR
Methods Mol Biol; 2019; 2033():15-24. PubMed ID: 31332744
[TBL] [Abstract][Full Text] [Related]
4. High-Throughput Cysteine Scanning To Identify Stable Antibody Conjugation Sites for Maleimide- and Disulfide-Based Linkers.
Ohri R; Bhakta S; Fourie-O'Donohue A; Dela Cruz-Chuh J; Tsai SP; Cook R; Wei B; Ng C; Wong AW; Bos AB; Farahi F; Bhakta J; Pillow TH; Raab H; Vandlen R; Polakis P; Liu Y; Erickson H; Junutula JR; Kozak KR
Bioconjug Chem; 2018 Feb; 29(2):473-485. PubMed ID: 29425028
[TBL] [Abstract][Full Text] [Related]
5. Homogeneous bispecifics by disulfide bridging.
Hull EA; Livanos M; Miranda E; Smith ME; Chester KA; Baker JR
Bioconjug Chem; 2014 Aug; 25(8):1395-401. PubMed ID: 25033024
[TBL] [Abstract][Full Text] [Related]
6. Practical synthesis of maleimides and coumarin-linked probes for protein and antibody labelling via reduction of native disulfides.
Song HY; Ngai MH; Song ZY; MacAry PA; Hobley J; Lear MJ
Org Biomol Chem; 2009 Sep; 7(17):3400-6. PubMed ID: 19675893
[TBL] [Abstract][Full Text] [Related]
7. Selective disulfide reduction for labeling and enhancement of Fab antibody fragments.
Kirley TL; Greis KD; Norman AB
Biochem Biophys Res Commun; 2016 Nov; 480(4):752-757. PubMed ID: 27983990
[TBL] [Abstract][Full Text] [Related]
8. In situ maleimide bridging of disulfides and a new approach to protein PEGylation.
Schumacher FF; Nobles M; Ryan CP; Smith ME; Tinker A; Caddick S; Baker JR
Bioconjug Chem; 2011 Feb; 22(2):132-6. PubMed ID: 21271715
[TBL] [Abstract][Full Text] [Related]
9. Sequential proteolysis and high-field FTICR MS to determine disulfide connectivity and 4-maleimide TEMPO spin-label location in L126C GM2 activator protein.
Tipton JD; Carter JD; Mathias JD; Emmett MR; Fanucci GE; Marshall AG
Anal Chem; 2009 Sep; 81(18):7611-7. PubMed ID: 19689113
[TBL] [Abstract][Full Text] [Related]
10. Polymeric dibromomaleimides as extremely efficient disulfide bridging bioconjugation and pegylation agents.
Jones MW; Strickland RA; Schumacher FF; Caddick S; Baker JR; Gibson MI; Haddleton DM
J Am Chem Soc; 2012 Jan; 134(3):1847-52. PubMed ID: 22188166
[TBL] [Abstract][Full Text] [Related]
11. Homogeneous antibody-drug conjugates via site-selective disulfide bridging.
Forte N; Chudasama V; Baker JR
Drug Discov Today Technol; 2018 Dec; 30():11-20. PubMed ID: 30553515
[TBL] [Abstract][Full Text] [Related]
12. Evidence of disulfide bond scrambling during production of an antibody-drug conjugate.
Liu-Shin LP; Fung A; Malhotra A; Ratnaswamy G
MAbs; 2018; 10(8):1190-1199. PubMed ID: 30339473
[TBL] [Abstract][Full Text] [Related]
13. Photochemically re-bridging disulfide bonds and the discovery of a thiomaleimide mediated photodecarboxylation of C-terminal cysteines.
Richards DA; Fletcher SA; Nobles M; Kossen H; Tedaldi L; Chudasama V; Tinker A; Baker JR
Org Biomol Chem; 2016 Jan; 14(2):455-459. PubMed ID: 26603469
[TBL] [Abstract][Full Text] [Related]
14. Aryloxymaleimides for cysteine modification, disulfide bridging and the dual functionalization of disulfide bonds.
Marculescu C; Kossen H; Morgan RE; Mayer P; Fletcher SA; Tolner B; Chester KA; Jones LH; Baker JR
Chem Commun (Camb); 2014 Jul; 50(54):7139-42. PubMed ID: 24853662
[TBL] [Abstract][Full Text] [Related]
15. Site Selective and Efficient Spin Labeling of Proteins with a Maleimide-Functionalized Trityl Radical for Pulsed Dipolar EPR Spectroscopy.
Jassoy JJ; Heubach CA; Hett T; Bernhard F; Haege FR; Hagelueken G; Schiemann O
Molecules; 2019 Jul; 24(15):. PubMed ID: 31357628
[TBL] [Abstract][Full Text] [Related]
16. Transglutaminase-based chemo-enzymatic conjugation approach yields homogeneous antibody-drug conjugates.
Dennler P; Chiotellis A; Fischer E; Brégeon D; Belmant C; Gauthier L; Lhospice F; Romagne F; Schibli R
Bioconjug Chem; 2014 Mar; 25(3):569-78. PubMed ID: 24483299
[TBL] [Abstract][Full Text] [Related]
17. Characterization of Disulfide Bond Rebridged Fab-Drug Conjugates Prepared Using a Dual Maleimide Pyrrolobenzodiazepine Cytotoxic Payload.
Ruddle BT; Fleming R; Wu H; Gao C; Dimasi N
ChemMedChem; 2019 Jun; 14(12):1185-1195. PubMed ID: 30980702
[TBL] [Abstract][Full Text] [Related]
18. Maleimidocysteineamido-DOTA derivatives: new reagents for radiometal chelate conjugation to antibody sulfhydryl groups undergo pH-dependent cleavage reactions.
Lewis MR; Shively JE
Bioconjug Chem; 1998; 9(1):72-86. PubMed ID: 9460549
[TBL] [Abstract][Full Text] [Related]
19. Protein modification, bioconjugation, and disulfide bridging using bromomaleimides.
Smith ME; Schumacher FF; Ryan CP; Tedaldi LM; Papaioannou D; Waksman G; Caddick S; Baker JR
J Am Chem Soc; 2010 Feb; 132(6):1960-5. PubMed ID: 20092331
[TBL] [Abstract][Full Text] [Related]
20. Bis(vinylsulfonyl)piperazines as efficient linkers for highly homogeneous antibody-drug conjugates.
Huang R; Sheng Y; Wei D; Yu J; Chen H; Jiang B
Eur J Med Chem; 2020 Mar; 190():112080. PubMed ID: 32018094
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
